Decoy Therapeutics Inc. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Decoy Therapeutics Inc. payments for repurchase of equity for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. payments for repurchase of equity for the quarter ending 2018-12-31 was $365.01K.
- Decoy Therapeutics Inc. payments for repurchase of equity for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Decoy Therapeutics Inc. payments for repurchase of equity for fiscal 2018 was $615.01K.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $0.00 10-K · filed 2020-03-23 |
| 2018-12-31 | $365.01K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $615.01K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |